Senores Pharmaceuticals Limited has informed the Exchange regarding Cessation of Company Secretary and Compliance Offer w.e.f. June 10, 2026
SENORES · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Senores Pharmaceuticals Limited has informed the stock exchange that its Company Secretary and Compliance Officer has ceased from the role, effective June 10, 2026. The Company Secretary is a key managerial personnel responsible for ensuring regulatory compliance, board governance, and timely disclosures. The company has not yet announced a replacement in this filing. Investors should watch for an update on the new appointment in subsequent filings.
This is a routine KMP-level exit and is unlikely to materially impact the stock price. However, shareholders should monitor for a timely replacement to ensure continuity of compliance and corporate governance functions.